weight loss
Novo Nordisk’s therapy delivers significant weight loss in trial
June 25, 2025Research and Development Novo Nordisk, Obesity, obesity, weight loss, weight-related medical conditions
Novo Nordisk has announced promising results from its phase 3 REDEFINE 1 trial, showing that investigational weight loss therapy, CagriSema, …
Veru announces first patients enrolled in phase 2b trial for weight loss treatment
May 1, 2024Research and Development Obesity, Veru, Wegovy, enobosarm, weight loss
Veru has announced that it has enrolled the first patients into its phase 2b clinical trial of enobosarm, an oral …
Lipocine announces results from phase 2 trial for obesity drug
April 12, 2024Research and Development Lipocine, Obesity, clinical trial, weight loss
Lipocine Inc has announced results from its phase 2 clinical trial (NCT04134091), which includes results for LPCN 2401, the company’s …
Eli Lilly’s Zepbound approved by FDA for chronic weight management
November 9, 2023Medical Communications Eli Lilly, FDA, Obesity, Zepbound, weight loss, weight management
Eli Lilly has announced that the US Food and Drug Administration (FDA) has approved Zepbound (tirzepatide) injection for chronic weight …
Novo Nordisk launches Wegovy in the UK
September 4, 2023Medical Communications NHS, NICE, Novo Nordisk, Obesity, Wegovy, weight loss
Novo Nordisk has today announced that Wegovy (semaglutide injection) is now available in the UK through a controlled and limited …
Eli Lilly shares data from two phase 3 tirzepatide studies
July 28, 2023Research and Development Eli Lilly, Obesity, clinical trial, tirzepatide, weight loss
Eli Lilly has announced results from its two phase 3 tirezepatide studies in adult patients with obesity or who are …
Eisai’s weight loss drug lorcaserin found safe in major study
August 28, 2018Manufacturing and Production, Research and Development, Sales and Marketing Eisai, lorcaserin, safety, study, weight loss
Eisai’s weight loss drug lorcaserin does not increase people’s risk of major cardiovascular events according to a study of 12,000 …
Drug combinations can boost weight loss, research finds
July 19, 2017Research and Development biotech, drugs, healthcare, obesity, pharma, pharmaceuticals, weight loss
Researchers at the Perelman School of Medicine at the University of Pennsylvania have found that by combining specific hormone-based drugs …
Novo Nordisk presents positive long-term results for Saxenda
June 3, 2016Medical Communications, Research and Development Novo Nordisk, cardiometabolic risk factors, liraglutide, saxenda, weight loss
Novo Nordisk has presented analysis covering three years of a late-stage trial for Saxenda (liarglutide 3mg) , which showed the …
Alli bottles tampered with in US, drug recalled
March 27, 2014Manufacturing and Production, Sales and Marketing Alli, FDA, GSK, Roche, Xenical, obesity, weight loss
GlaxoSmithKline has admitted that some bottles of its weight-loss drug Alli bought in the US have been tampered with. US …
